Study: OUD Patients More Likely to Stay on Methadone Than Buprenorphine/Naloxone
Patients with opioid use disorder (OUD) had a lower risk of discontinuing methadone compared with buprenorphine/naloxone, and with a similar ...
Day: October 18, 2024
‘Virtual ED’ Helps One Health System Avoid Unnecessary Emergency Department Visits
WASHINGTON -- Use of a "virtual" emergency department (ED) has saved several patients from unnecessary ED trips in its first ...
FDA OKs Zolbetuximab for Gastric, Gastroesophageal Cancer
The US Food and Drug Administration (FDA) has approved zolbetuximab (Vyloy, Astellas Pharma) in combination with fluoropyrimidine and platinum-containing chemotherapy ...
Novel Targeted Drug Approved for Stomach Cancers
The FDA approved zolbetuximab (Vyloy), a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, in combination with chemotherapy for the first-line treatment of ...
Diet and Prostate Cancer; TTFields OK’d for NSCLC; Cancer Studies Retracted
A healthy diet in prostate cancer patients on active surveillance was associated with a reduced risk of progressing to a ...
Tpoxx No Better Than Placebo for Clade I Mpox
The antiviral drug tecovirimat (Tpoxx) failed to shorten the duration of mpox lesions or lower mortality among children and adults ...
Teen Smoking, Other Tobacco Use Dropped to Lowest Level in 25 Years, CDC Reports
Teen smoking hit an all-time low in the U.S. this year, part of a big drop in the use of ...
FDA OKs Novel Levodopa-Based Regimen for Parkinson’s
The US Food and Drug Administration (FDA) has approved foscarbidopa and foslevodopa (Vyalev, AbbVie), a solution of carbidopa and levodopa ...
Immunotherapy and Immune-Related Adverse Events
While immunotherapy has revolutionized the way in which oncologists treat cancer, its use comes with a variety of side effects ...
Drugmaker Pulls Trodelvy’s Bladder Cancer Approval
Sacituzumab govitecan's (Trodelvy) accelerated approval in urothelial cancer will be voluntarily withdrawn, Gilead Sciences announced on Friday. The decision was ...
Boosting brain waves in sleep improves rats’ memory
Illustration of neuron activity in a rat’s brainConnect Images/Alamy Strengthening activity of some brainwaves in rats’ while they sleep improves ...
New Flu and Updated COVID Vaccines Greenlighted by Europe
Europe's Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization for two vaccines: Fluad (surface antigen, inactivated, ...
Generic Medicine OKd by Europe for Thrombocytopenia With HCV
Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization for Eltrombopag Viatris (eltrombopag), a ...
EMA Confirms Rejection of Neurodegenerative Disease Drugs
The European Medicines Agency (EMA) has upheld an earlier recommendation to deny marketing authorization for Masitinib AB Science (masitinib), an ...
Doctors, Not AI, Should Authorize Treatments
Kanaparthy is a practicing internal medicine physician specializing in clinical informatics. Last month, California passed a bill ensuring that doctors, ...
How Does This Year’s Flu Shot Stack Up?
Data from the southern hemisphere show that this year's flu shot was 34.5% effective against hospitalization in high-risk groups during ...
CDC Reminds Docs About This Flesh-Eating Worm
A type of flesh-eating worm eradicated from the U.S. in the 1960s has been spotted again in Central America, prompting ...
MedPod Today: Med Ed Drama; Chiropractic in Academia; MA ‘Extra Benefits’ Worth It?
The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody, welcome to MedPod Today, the podcast series ...
Serious Battery Issue Prompts Medtronic Insulin Pump Recall
A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the ...
Gene Therapy Details Revealed in Duchenne Trial
SAVANNAH, Ga. -- Delandistrogene moxeparvovec (Elevidys), a gene therapy approved to treat Duchenne muscular dystrophy, missed its primary endpoint but ...
